Novartis's older MS drug Gilenya wins Chinese approval

Novartis's Gilenya multiple sclerosis drug has won approval in China, the Swiss drugmaker said on Friday, as the company expands further into the world's most-populous country's growing healthcare sector.

Women doctors skip conferences because of family responsibilities

(Reuters Health) - Female cancer experts are more likely than their male colleagues to skip scientific meetings that could offer networking opportunities and a chance to catch up with the latest developments in their field, a new study finds.

Exclusive: Canada warns U.S. against drug import plans, citing shortage concerns

Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country's drug supply or raise costs for its own citizens, officials have told U.S. authorities, in a new setback to the Trump administration's efforts to tackle high drug prices, according to documents obtained by Reuters.

Illinois to defy Trump administration's abortion referral 'gag rule'

Illinois will defy enforcement of the Trump administration's rule barring federally subsidized family planning clinics from making abortion referrals, the governor said on Thursday, vowing the state would step in to fund most of those clinics itself.

Trump EPA allows use of controversial pesticide

The Environmental Protection Agency on Thursday said it will not ban the use of the pesticide chlorpyrifos, which has been linked to health issues in children, from use on U.S.-grown fruits and vegetables.

Second opioid distributor charged over role in U.S. drug epidemic

An Ohio drug wholesale distributor and two former executives were charged on Thursday with profiting from the U.S. opioid epidemic by selling millions of pills despite signs the addictive drugs were being misused.

Biden versus Sanders: Top 2020 contenders snipe over healthcare policy

Democratic presidential front-runner Joe Biden and rival Bernie Sanders are waging a public battle this week over universal healthcare, staking out competing turf on an issue that has become the most divisive in the party's primary campaign.

WHO flags Ebola risk in Rwanda, but then withdraws its report

The World Health Organization on Thursday withdrew a report that said an Ebola patient may have entered Rwanda, suggesting the deadly virus could spread to that country for the first time.

Night shifts, long hours linked to miscarriages and preterm births

(Reuters Health) - Pregnant women who work nights or long hours may be more likely to have a miscarriage or preterm delivery than mothers with day jobs, a research review suggests.

Recent cannabis use tied to memory deficits, slowed mental processing

(Reuters Health) - People who have recently used cannabis may be more likely to experience memory deficits or difficulties with cognitive function than those who don't use the drug, a recent study suggests.

Young men 'benefit' in later years when teen pregnancy ends in abortion

When young women use abortion services, the adolescent men who avoid becoming teenaged fathers go on to have better educational and financial futures than peers who do become teen fathers, a U.S. study suggests.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS